The CEP290 gene helps cells build and maintain cilia, which are tiny hairlike structures that act like antennae and transport routes. When this gene does not work properly, cilia may not function well, which can lead to inherited conditions that affect vision early in life and, in some people, also the kidneys, brain, or development. Some people first learn about this gene when genetic testing looks for causes of Leber congenital amaurosis, a condition linked to certain CEP290 variants. Effects can vary a lot from one person to another.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, which are the active working parts of cells. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
CEP290Gene function
What if the gene works
The CEP290 gene helps build and maintain cilia, tiny hair-like structures on cells. These structures help cells sense signals and move key proteins, especially in the eyes, kidneys, and brain.
Risk
What if the gene does not work
Variants in the CEP290 gene can disrupt cilia, tiny cell structures that help organs develop and sense signals. Milder variants may mainly cause early vision loss, while more severe variants can also affect brain development, kidneys, or multiple organs.
Treatment
What does that mean for your treatment
For pathogenic variants in the CEP290 gene, no CEP290-specific treatment or management approach is currently established in clinical guidelines. The CEP290 gene is an active research target in inherited retinal disease, including antisense and CRISPR based therapies for some CEP290-related vision loss.
Conditions associated with CEP290
Gene function
What if the gene works
Many cells rely on the CEP290 gene for normal cilia function, keeping these tiny projections working smoothly. Cilia help cells sense their surroundings and move selected proteins to the right place. This makes the CEP290 gene important for day to day cell communication and organization.
The CEP290 gene helps cells build and anchor cilia at the cell surface. Its protein sits near the cilia base and supports the framework that keeps this tiny projection stable.
One of its main jobs is forming a checkpoint at the cilia base. This gateway guides which proteins move in and out, helping the cilium stay organized and ready to sense signals.
By keeping cilia organized, the CEP290 gene supports how cells receive and pass along outside messages. This helps routine communication that guides growth and tissue maintenance.
CEP290 also works near the centrosome, the cell area that helps position a cilium correctly. This supports orderly cell structure and gives the cilium a stable starting point.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How CEP290 gene variants affect the protein depends on the DNA change. Many variants disrupt splicing (the way a cell edits RNA instructions) or create a shortened, unstable protein that cannot properly reach or support cilia, the tiny hairlike structures on cells. Milder variants may leave some protein activity, while more severe variants can greatly reduce it or stop production altogether. This range often influences whether disease appears later and mainly affects vision, or starts earlier with broader ciliopathy features.
How variants are linked to conditions
Among the conditions linked to the CEP290 gene variants, the most established are Leber congenital amaurosis, Joubert syndrome, Senior-Løken syndrome, and some forms of Meckel syndrome. Pathogenic variants in the CEP290 gene can cause these inherited conditions, though the symptoms and severity can differ from person to person. Some people mainly have early vision loss, while others also have kidney, brain, or developmental findings.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology across the general population. Most do not directly affect health and simply contribute to natural human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CEP290, risk is mainly shaped by the specific gene changes inherited in a family, and symptoms can vary widely even among relatives. There is not yet broadly confirmed evidence that lifestyle or environmental factors clearly increase or reduce risk related to CEP290, so anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of CEP290 variants
For most CEP290-related conditions, the inheritance of the CEP290 gene variants follows an autosomal recessive pattern. This means a child usually inherits one variant in the CEP290 gene from each parent, and both parents are often healthy carriers. When both parents carry a CEP290 variant, each pregnancy has a 25% chance of producing a child with the condition, a 50% chance of producing a carrier, and a 25% chance of producing a child without either family variant. The CEP290 gene is on chromosome 12, so this pattern is the same for males and females.
What does my CEP290 result mean for my family?
For most health conditions linked to the CEP290 gene, the pattern is usually recessive, which means parents, brothers, sisters, and adult children may want to know whether they also carry the family’s gene change. Brothers and sisters can sometimes be affected or be carriers even if they feel well. Other relatives may also carry the same change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CEP290 gene, doctors use genetic testing for CEP290 variants on a blood, saliva, or cheek swab sample. A lab reads the gene’s DNA code and compares it with the usual sequence to look for variants that may help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
Genetic testing for the CEP290 gene can be worth considering if there is early-onset severe vision loss, especially vision problems starting in infancy, or a family history of inherited eye disease or certain rare conditions that also affect the kidneys, brain, or development. It can help confirm the cause and clarify family risk.
A genetic result is only one part of your health story
Genetic findings can offer valuable insight, but how much they reveal depends on the condition and on the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that helps one person may work less well in another, or may cause more side effects, partly because the body can absorb, break down, transport, or respond to a drug differently. These differences are common and can influence how effective a medicine feels and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way a person responds to medications. It focuses on links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. If you want to learn more about this topic, additional information is available in the LearnHub.
Drugs influenced by the CEP290 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices. Questions about medicines, side effects, or how treatments may affect your overall health are best discussed with your doctor or pharmacist.
History
The CEP290 gene entered medical genetics through studies of children and adults with inherited vision loss and related developmental conditions in the early 2000s. Initially understood only through visible traits, later recognized as tied to a specific gene, CEP290 became an important clue linking several conditions that had once seemed separate. Researchers then connected variants in the CEP290 gene to Leber congenital amaurosis, Joubert syndrome, and other ciliopathy conditions, helping doctors refine diagnosis. From these first observations, research expanded steadily. In later years, CEP290 drew wider scientific attention because it became one of the first genes explored in human studies using gene editing for an inherited eye condition, marking a notable step in precision medicine.